These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15081133)

  • 21. [Review and analysis of present status of the micronization of Chinese traditional medicine].
    Xu YH; Wang NS
    Zhongguo Zhong Yao Za Zhi; 2004 Jun; 29(6):497-500. PubMed ID: 15706908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Amorphization in pharmaceutical technology].
    Révész P; Laczkovich O; Eros I
    Acta Pharm Hung; 2004; 74(1):39-44. PubMed ID: 15524047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
    Mukherjee S; Ray S; Thakur RS
    Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Increasing the solubility and permeability of pharmacons with pharmaceutical technological methods].
    Aigner Z
    Acta Pharm Hung; 2008; 78(1):3-10. PubMed ID: 18476363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 109881 Aventis.
    Ojima I; Geney R
    Curr Opin Investig Drugs; 2003 Jun; 4(6):737-40. PubMed ID: 12901234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic analysis of pH-dependent solubility and trans-membrane permeability of amphoteric compounds: application to sildenafil.
    Wang Y; Chow MS; Zuo Z
    Int J Pharm; 2008 Mar; 352(1-2):217-24. PubMed ID: 18068319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of drug delivery technologies in lead candidate selection and optimization.
    Chaubal MV
    Drug Discov Today; 2004 Jul; 9(14):603-9. PubMed ID: 15239979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excipient hydrolysis and ester formation increase pH in a parenteral solution over aging.
    Hirakura Y; Nakamura M; Wakasawa T; Ban K; Yokota S; Kitamura S
    Int J Pharm; 2006 Nov; 325(1-2):26-38. PubMed ID: 16860951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug permeability across a phospholipid vesicle-based barrier 2. Characterization of barrier structure, storage stability and stability towards pH changes.
    Flaten GE; Bunjes H; Luthman K; Brandl M
    Eur J Pharm Sci; 2006 Jul; 28(4):336-43. PubMed ID: 16697561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system.
    Pouton CW
    Eur J Pharm Sci; 2006 Nov; 29(3-4):278-87. PubMed ID: 16815001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A one-pot method to enhance dissolution rate of low solubility drug molecules using dispersion polymerization in supercritical carbon dioxide.
    Galia A; Scialdone O; Filardo G; Spanò T
    Int J Pharm; 2009 Jul; 377(1-2):60-9. PubMed ID: 19439168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation of rifampicin-cyclodextrin complexes for lung nebulization.
    Tewes F; Brillault J; Couet W; Olivier JC
    J Control Release; 2008 Jul; 129(2):93-9. PubMed ID: 18514353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structure, crystal morphology, and surface properties of an investigational drug.
    Kiang YH; Yang CY; Staples RJ; Jona J
    Int J Pharm; 2009 Feb; 368(1-2):76-82. PubMed ID: 19007872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new approach in the prediction of the dissolution behavior of suspended particles by means of their particle size distribution.
    Tinke AP; Vanhoutte K; De Maesschalck R; Verheyen S; De Winter H
    J Pharm Biomed Anal; 2005 Oct; 39(5):900-7. PubMed ID: 16023816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclodextrins as pharmaceutical solubilizers.
    Brewster ME; Loftsson T
    Adv Drug Deliv Rev; 2007 Jul; 59(7):645-66. PubMed ID: 17601630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality by design - Spray drying of insulin intended for inhalation.
    Maltesen MJ; Bjerregaard S; Hovgaard L; Havelund S; van de Weert M
    Eur J Pharm Biopharm; 2008 Nov; 70(3):828-38. PubMed ID: 18755270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous measurement of liquid-phase and solid-phase transformation kinetics in rotating disc and channel flow cell dissolution devices.
    Lehto P; Aaltonen J; Niemelä P; Rantanen J; Hirvonen J; Tanninen VP; Peltonen L
    Int J Pharm; 2008 Nov; 363(1-2):66-72. PubMed ID: 18675891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.